This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Tacrolimus in psoriasis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Tacrolimus in psoriasis

Tacrolimus

  • is a macrolide calcineurin inhibitor that is produced by Streptomyces tsukubaensis
    • although tacrolimus and ciclosporin inhibit calcineurin leading to suppression of T-cell activation, tacrolimus has been found to have a more potent immunological effect with a diminished vasoconstrictive and fibrinogenic effect (1)

Topical and oral administration of tacrolimus has demonstrated considerable efficacy in the treatment of psoriasis (1)

  • with regard to topical tacrolimus therapy, particular utility has been observed in cases of inverse psoriasis and psoriasis affecting the face, genitalia, and nails
    • topical tacrolimus appears to have a role as a corticosteroid-sparing agent and may be associated with fewer side effects than other topical preparations
    • a systematic review stated that ".. studies demonstrated a considerable efficacy of topical administration of tacrolimus and pimecrolimus in the treatment of psoriasis, especially for facial, genital, and intertriginous areas.." (2)

Reference:

  • Malecic N, Young H. Tacrolimus for the management of psoriasis: clinical utility and place in therapy. Psoriasis (Auckl). 2016 Dec 7;6:153-163. doi: 10.2147/PTT.S101233. PMID: 29387602; PMCID: PMC5683124.
  • Dattola A, Silvestri M, Bennardo L, Del Duca E, Longo C, Bianchi L, Nisticò S. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review. Dermatol Ther. 2018 Nov;31(6):e12728. doi: 10.1111/dth.12728. Epub 2018 Oct 8. PMID: 30295379.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.